Matinas BioPharma Holdings MTNB
NYSE MTNB
$0.19 +0.01 (+4.11%)
As of: Aug 21, 2026 · 12:12 PM EDT

Matinas BioPharma Holdings (MTNB) FCF Margin (QoQ) (2015 - 2023)

Matinas BioPharma Holdings (MTNB) FCF Margin (QoQ) (2015 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.79 Bn 131.94 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.74 Bn 78.74 Bn 3.93 Bn
3 Argenx Se 65.48 Bn 60.29 Bn 1.37 Bn
4 Moderna 59.32 Bn 54.18 Bn 52.00 Mn
5 BeOne Medicines 42.08 Bn 36.98 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.81 Bn 28.50 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.56 Bn 26.40 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Matinas BioPharma Holdings 1.22 Mn 406,176.27 -

Historic Data

Download Data
DateValue
Jun 30, 2023 78,571.00
Mar 31, 2023 -68,149.00
Dec 31, 2022 8,269.00
Sep 30, 2022 -320.00
Mar 31, 2021 -2.08 Mn
Dec 31, 2020 1.23 Mn
Jun 30, 2018 702,115.00
Mar 31, 2018 -518,373.00
Dec 31, 2017 174,862.00
Sep 30, 2017 202,368.00
Jun 30, 2017 1.20 Mn
Sep 30, 2015 -70,733.00
Jun 30, 2015 111,590.00